IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pivotal bioVenture Partners Investment Advisor LLC

Q1 2025 Holdings

Filed 2025-05-14 | 11 holdings | $123.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Oculis Holding AG(OCS)ORDINARY SHARESH5870P102$43.8M2,300,77435.4%
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$33.2M2,120,50826.8%
Vaxcyte Inc(PCVX)COM92243G108$26.8M710,73421.7%
Zenas Biopharma Inc(ZBIO)COM98937L105$5.8M736,6454.7%
Inozyme Pharma IncCOM45790W108$4.1M4,494,8513.3%
Recursion Pharmaceuticals in(RXRX)CL A75629V104$3.2M595,5182.5%
Bioage Labs Inc(BIOA)COM09077V100$2.5M653,3742.0%
Rallybio CorpCOM75120L100$1.6M2,404,6441.3%
Vigil Neuroscience Inc(VIGL)COM92673K108$997.9K560,5950.8%
IO Biotech Inc(IOBT)COM449778109$942.0K864,1970.8%
Bolt Biotherapeutics Inc(BOLT1EUR)COM097702104$756.6K1,891,4670.6%